Research Article
Prognostic Significance of Microvessel Density Determining by Endoglin in Stage II Rectal Carcinoma: A Retrospective Analysis
Table 2
CD105-MVD and clinicopathological factors in patients with rectal cancer.
| | Variable | Patients
(%) | CD105-MVD
median (95% CI) | value |
| | Age, median 69 years | | | | | ≤69 | 49 (51.6) | 192.8 (152.6–296.1) | | | >69 | 46 (48.4) | 164.2 (125.8–192.2) | | | Gender | | | | | Male | 61 (64.2) | 171.5 (124.7–206.0) | | | Female | 34 (35.8) | 184.6 (159.4–247.3) | | | Tumor location | | | | | Upper rectum | 23 (24.2) | 200.9 (165.2–285.8) | | | Middle rectum | 52 (54.7) | 178.9 (136.2–240.5) | | | Low rectum | 20 (21.1) | 125.8 (106.2–194.9) | | | Grade of differentiation | | | | | G1 | 55 (57.9) | 171.5 (127.0–192.3) | | | G2 | 34 (35.8) | 191.7 (124.1–289.2) | | | G3 | 6 (6.3) | 267.1 (105.6–578.2) | | | Histologic type | | | | | Adenocarcinoma | 82 (86.3) | 173.2 (137.1–193.4) | | | Adenocarcinoma with mucinous features | 13 (13.7) | 235.2 (127.3–423.8) | | | Depth of tumor invasion | | | | | T3 | 37 (38.9) | 173.2 (120.1–189.2) | | | T4a | 42 (44.2) | 205.0 (151.1–315.0) | | | T4b | 16 (16.9) | 151.1 (95.4–292.7) | | | Tumor size | | | | | ≤4 cm | 64 (67.4) | 175.6 (131.4–197.8) | | | >4 cm | 31 (32.6) | 196.1 (142.7–244.7) | |
|
|
Mann-Whitney test; Kruskal-Wallis test.
|
